Magdalena Espinoza

460 total citations
25 papers, 282 citations indexed

About

Magdalena Espinoza is a scholar working on Oncology, Public Health, Environmental and Occupational Health and Statistics, Probability and Uncertainty. According to data from OpenAlex, Magdalena Espinoza has authored 25 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 5 papers in Public Health, Environmental and Occupational Health and 5 papers in Statistics, Probability and Uncertainty. Recurrent topics in Magdalena Espinoza's work include Cancer Immunotherapy and Biomarkers (7 papers), scientometrics and bibliometrics research (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Magdalena Espinoza is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), scientometrics and bibliometrics research (5 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Magdalena Espinoza collaborates with scholars based in United States, Taiwan and Austria. Magdalena Espinoza's co-authors include Antony Hsieh, David Hsiehchen, Paul Slovic, Muhammad Shaalan Beg, Hao Zhu, Amit G. Singal, Waqas Haque, Adam C. Yopp, N Velasco and Cristina Valero and has published in prestigious journals such as JAMA, Gastroenterology and PLoS ONE.

In The Last Decade

Magdalena Espinoza

23 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Magdalena Espinoza United States 10 70 47 42 39 38 25 282
James Cunningham United States 12 58 0.8× 20 0.4× 57 1.4× 14 0.4× 3 0.1× 42 485
John Crowley Canada 6 47 0.7× 55 1.2× 11 0.3× 57 1.5× 13 0.3× 12 696
Yash Pershad United States 9 36 0.5× 6 0.1× 31 0.7× 21 0.5× 15 0.4× 25 479
Angela K. Green United States 12 170 2.4× 8 0.2× 3 0.1× 83 2.1× 91 2.4× 23 508
Kelly Lien Canada 10 232 3.3× 4 0.1× 17 0.4× 16 0.4× 74 1.9× 25 433
Daniel Feldman United States 10 48 0.7× 10 0.2× 3 0.1× 53 1.4× 58 1.5× 28 644
Katherine A. Kelley United States 18 186 2.7× 5 0.1× 55 1.3× 358 9.2× 126 3.3× 68 1.0k
Betsy Rolland United States 11 97 1.4× 21 0.4× 4 0.1× 90 2.3× 8 0.2× 36 361
Peter B. Morgan United States 12 19 0.3× 16 0.3× 4 0.1× 12 0.3× 8 0.2× 24 410
Michelle Xia United States 9 58 0.8× 11 0.2× 18 0.4× 5 0.1× 13 0.3× 34 212

Countries citing papers authored by Magdalena Espinoza

Since Specialization
Citations

This map shows the geographic impact of Magdalena Espinoza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Magdalena Espinoza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Magdalena Espinoza more than expected).

Fields of papers citing papers by Magdalena Espinoza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Magdalena Espinoza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Magdalena Espinoza. The network helps show where Magdalena Espinoza may publish in the future.

Co-authorship network of co-authors of Magdalena Espinoza

This figure shows the co-authorship network connecting the top 25 collaborators of Magdalena Espinoza. A scholar is included among the top collaborators of Magdalena Espinoza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Magdalena Espinoza. Magdalena Espinoza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Espinoza, Magdalena, et al.. (2026). Primary and secondary pseudo-stability and progression after atezolizumab with and without bevacizumab. Journal for ImmunoTherapy of Cancer. 14(1). e013727–e013727.
2.
Haque, Waqas, et al.. (2025). Disrupted Federal Funding for Extramural Cancer Research. JAMA Oncology. 12(1). 109–109.
3.
Espinoza, Magdalena, et al.. (2025). Complete Response to Immunotherapy in Patients With Hepatocellular Carcinoma. JAMA Network Open. 8(2). e2461735–e2461735. 2 indexed citations
4.
Espinoza, Magdalena, Andrew Elliott, Joanne Xiu, et al.. (2024). Tissue-specific thresholds of mutation burden associated with anti-PD-1/L1 therapy benefit and prognosis in microsatellite-stable cancers. Nature Cancer. 5(7). 1121–1129. 11 indexed citations
5.
Espinoza, Magdalena, et al.. (2023). Treatment Beyond Progression After Anti-PD-1 Blockade in Hepatocellular Carcinoma. Cancer Research Communications. 3(9). 1912–1916. 4 indexed citations
6.
Espinoza, Magdalena, et al.. (2023). Disease Etiology and Outcomes After Atezolizumab Plus Bevacizumab in Hepatocellular Carcinoma: Post-Hoc Analysis of IMbrave150. Gastroenterology. 165(1). 286–288.e4. 32 indexed citations
7.
Espinoza, Magdalena. (2022). Cultura de Paz y salud mental en los colaboradores. 6. 385–401. 1 indexed citations
8.
Pham, Tri Nhut, et al.. (2022). Representation of Investigators by Gender Among Authors of Phase 3 Oncology Trials Worldwide. JAMA Network Open. 5(2). e220031–e220031. 4 indexed citations
9.
Hsiehchen, David, Magdalena Espinoza, David E. Gerber, & Muhammad Shaalan Beg. (2021). Clinical and biological determinants of circulating tumor DNA detection and prognostication using a next-generation sequencing panel assay. Cancer Biology & Therapy. 22(7-9). 455–464. 12 indexed citations
10.
Haque, Waqas, et al.. (2021). Industry Payments Are Prevalent and Contagious in Subspecialty Medical Education. Journal of General Internal Medicine. 36(10). 3257–3260. 2 indexed citations
11.
Hsiehchen, David, Magdalena Espinoza, Cristina Valero, Chul Ahn, & Luc G.T. Morris. (2021). Impact of tumor mutational burden on checkpoint inhibitor drug eligibility and outcomes across racial groups. Journal for ImmunoTherapy of Cancer. 9(11). e003683–e003683. 17 indexed citations
12.
Espinoza, Magdalena, et al.. (2020). Characteristics of Faculty Accused of Academic Sexual Misconduct in the Biomedical and Health Sciences. JAMA. 323(15). 1503–1503. 9 indexed citations
13.
Espinoza, Magdalena, et al.. (2020). Political partisanship and mobility restriction during the COVID-19 pandemic. Public Health. 187. 111–114. 41 indexed citations
14.
Hsieh, Antony, et al.. (2019). Prevalence of Female Authors in Case Reports Published in the Medical Literature. JAMA Network Open. 2(5). e195000–e195000. 12 indexed citations
15.
Espinoza, Magdalena, et al.. (2018). A Fatal Case of Severe Lactic Acidosis and Acute Liver Failure in a Patient with Primary Hepatic Lymphoma. The American Journal of Gastroenterology. 113(Supplement). S1243–S1244. 1 indexed citations
16.
Espinoza, Magdalena, et al.. (2016). Disease burden and the advancement of biomedical knowledge. Scientometrics. 110(1). 321–333. 2 indexed citations
17.
Espinoza, Magdalena, Antony Hsieh, & David Hsiehchen. (2016). Systematic characterization of gastrointestinal clinical trials. Digestive and Liver Disease. 48(5). 480–488. 2 indexed citations
18.
Espinoza, Magdalena, et al.. (2015). Hypoallometric scaling in international collaborations. Physica A Statistical Mechanics and its Applications. 444. 188–193. 3 indexed citations
19.
Espinoza, Magdalena, et al.. (2015). The Cooperative Landscape of Multinational Clinical Trials. PLoS ONE. 10(6). e0130930–e0130930. 9 indexed citations
20.
Csendes, Attila, et al.. (1981). Perimeter and Location of the Muscular Gastroesophageal Junction or ‘Cardia’ in Control Subjects and in Patients with Reflux Esophagitis or Achalasia. Scandinavian Journal of Gastroenterology. 16(7). 951–956. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James Cunningham Breakdown of academic impact, for papers by John Crowley Breakdown of academic impact, for papers by Yash Pershad Breakdown of academic impact, for papers by Angela K. Green Breakdown of academic impact, for papers by Kelly Lien Breakdown of academic impact, for papers by Daniel Feldman Breakdown of academic impact, for papers by Katherine A. Kelley Breakdown of academic impact, for papers by Betsy Rolland Breakdown of academic impact, for papers by Peter B. Morgan Breakdown of academic impact, for papers by Michelle Xia
Rankless by CCL
2026